The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and ...

Antibiotic use in preterm infants is linked to gut microbiome changes, increasing susceptibility to infections and impacting ...

Infants who survive serious health problems in the first few weeks of life have a higher risk of dying during childhood and ...

The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...

Probiotics added to infant feeds have the potential to prevent sensitisation of infants to dietary allergens. Objectives: To evaluate the benefits and harms of a probiotic, or a probiotic with added ...

The Food and Drug Administration has approved a new drug from Merck designed to protect infants from respiratory syncytial ...

After decades of stalled national progress in reducing the rate of Sudden Unexpected Infant Death (SUID), a category of ...

Water sampling results done Saturday revealed nitrate levels of 11.9 milligrams per liter, according to Aqua Water. The ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's existing treatment.

Aqua Illinois advises University Park, Peotone and Kankakee residents not to give tap water to infants due to high nitrate ...